PRTN3 suppresses cytotoxic immune-cell activation and antitumoral immunity through proteolytic cleavage of CXCL9 in KRAS mutant lung adenocarcinoma
Ontology highlight
ABSTRACT: PRTN3 suppresses cytotoxic immune-cell activation and antitumoral immunity through proteolytic cleavage of CXCL9 in KRAS mutant lung adenocarcinoma
PROVIDER: PRJNA1132973 | ENA |
REPOSITORIES: ENA
ACCESS DATA